Synergy Innovation Co. Ltd Asset Resilience Ratio
Synergy Innovation Co. Ltd asset resilience ratio. Synergy Innovation Co. Ltd (048870) has an Asset Resilience Ratio of 13.21% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 048870 days of operational coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Synergy Innovation Co. Ltd (2006–2025)
Asset resilience ratio of Synergy Innovation Co. Ltd from 2006 to 2025. This chart shows how Synergy Innovation Co. Ltd's Asset Resilience Ratio has changed over time. Read debt load of Synergy Innovation Co. Ltd for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Synergy Innovation Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see balance sheet size of Synergy Innovation Co. Ltd.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩45.61 Billion | 13.21% |
| Total Liquid Assets | ₩45.61 Billion | 13.21% |
Asset Resilience Insights
- Moderate Liquidity: Synergy Innovation Co. Ltd has 13.21% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Synergy Innovation Co. Ltd Industry Peers by Asset Resilience Ratio
Compare Synergy Innovation Co. Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Hyloris Developmentsen Sa
BR:HYL |
Biotechnology | 1.36% |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN |
Biotechnology | 0.00% |
|
Oruka Therapeutics, Inc.
NASDAQ:ORKA |
Biotechnology | 53.11% |
|
Gempharmatech Co. Ltd. A
SHG:688046 |
Biotechnology | 23.95% |
|
Vor Biopharma Inc
NASDAQ:VOR |
Biotechnology | 74.48% |
|
Inventiva S.A
PA:IVA |
Biotechnology | 52.73% |
|
Sunmax Biotechnology Co Ltd
TWO:4728 |
Biotechnology | 10.53% |
|
Guangdong VTR Bio-Tech Co Ltd
SHE:300381 |
Biotechnology | 4.98% |
Synergy Innovation Co. Ltd Asset Resilience Ratio by Year (2006–2025)
Synergy Innovation Co. Ltd asset resilience ratio by year from 2006 to 2025. The table below shows the annual Asset Resilience Ratio data for Synergy Innovation Co. Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 5.10% | ₩17.17 Billion ≈ $11.64 Million |
₩336.89 Billion ≈ $228.30 Million |
-6.06pp |
| 2024-12-31 | 11.16% | ₩35.05 Billion ≈ $23.75 Million |
₩314.06 Billion ≈ $212.83 Million |
-3.77pp |
| 2023-12-31 | 14.93% | ₩42.69 Billion ≈ $28.93 Million |
₩285.90 Billion ≈ $193.75 Million |
+13.77pp |
| 2022-12-31 | 1.16% | ₩2.64 Billion ≈ $1.79 Million |
₩227.38 Billion ≈ $154.09 Million |
-15.05pp |
| 2021-12-31 | 16.21% | ₩32.85 Billion ≈ $22.26 Million |
₩202.70 Billion ≈ $137.37 Million |
-0.47pp |
| 2020-12-31 | 16.68% | ₩26.40 Billion ≈ $17.89 Million |
₩158.31 Billion ≈ $107.29 Million |
+7.04pp |
| 2019-12-31 | 9.64% | ₩14.20 Billion ≈ $9.62 Million |
₩147.29 Billion ≈ $99.82 Million |
-12.96pp |
| 2018-12-31 | 22.60% | ₩27.57 Billion ≈ $18.69 Million |
₩122.01 Billion ≈ $82.68 Million |
+15.07pp |
| 2017-12-31 | 7.53% | ₩7.98 Billion ≈ $5.41 Million |
₩106.06 Billion ≈ $71.87 Million |
-2.99pp |
| 2016-12-31 | 10.52% | ₩6.27 Billion ≈ $4.25 Million |
₩59.67 Billion ≈ $40.44 Million |
+6.68pp |
| 2015-12-31 | 3.83% | ₩616.99 Million ≈ $418.12K |
₩16.10 Billion ≈ $10.91 Million |
-16.76pp |
| 2014-12-31 | 20.59% | ₩16.90 Billion ≈ $11.45 Million |
₩82.08 Billion ≈ $55.62 Million |
+3.10pp |
| 2013-12-31 | 17.49% | ₩16.89 Billion ≈ $11.44 Million |
₩96.56 Billion ≈ $65.44 Million |
+5.28pp |
| 2012-12-31 | 12.21% | ₩15.90 Billion ≈ $10.77 Million |
₩130.20 Billion ≈ $88.24 Million |
-11.71pp |
| 2011-12-31 | 23.92% | ₩30.15 Billion ≈ $20.43 Million |
₩126.03 Billion ≈ $85.41 Million |
+1.75pp |
| 2009-12-31 | 22.17% | ₩31.70 Billion ≈ $21.48 Million |
₩143.00 Billion ≈ $96.91 Million |
-25.34pp |
| 2008-12-31 | 47.51% | ₩85.27 Billion ≈ $57.78 Million |
₩179.47 Billion ≈ $121.63 Million |
-2.02pp |
| 2007-12-31 | 49.53% | ₩77.56 Billion ≈ $52.56 Million |
₩156.60 Billion ≈ $106.13 Million |
+24.85pp |
| 2006-12-31 | 24.67% | ₩33.75 Billion ≈ $22.87 Million |
₩136.78 Billion ≈ $92.69 Million |
-- |
About Synergy Innovation Co. Ltd
Synergy Innovation Co., Ltd. engages in the research and development, and investment of generic and new drugs, medical devices, and health functional foods in South Korea. It produces and sells various culture media for hospitals, pharmaceuticals, and food/cosmetics; manufactures synergy innovation " universal transport solutions (SI-UTS); and invests and develops in various fields comprising mic… Read more